Clinical Features of Borderline Ovarian Seromucinous Tumor.

Nagayoshi, Yoko; Yamada, Kyosuke; Kiyokawa, Takako; Fukasawa, Nei; Kuroda, Takafumi; Noguchi, Daito; Okamoto, Aikou

Nagayoshi, Yoko; Yamada, Kyosuke; Kiyokawa, Takako; Fukasawa, Nei; Kuroda, Takafumi; Noguchi, Daito; Okamoto, Aikou.

Afiliación

Nagayoshi Y; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato, Japan.
Yamada K; Gynecologic Oncology Center/Gynecology, International University of Health and Welfare, Mita Hospital, Minato, Japan.
Kiyokawa T; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato, Japan.
Fukasawa N; Department of Pathology, The Jikei University School of Medicine, Minato, Japan.
Kuroda T; Department of Pathology, The Jikei University School of Medicine, Minato, Japan.
Noguchi D; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato, Japan.
Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Minato, Japan.

Cancer Diagn Progn ; 3(3): 360-364, 2023.

Article en En | MEDLINE | ID: mdl-37168956

Palabras clave

CA-19-9 antigen; cystadenofibroma; endometriosis; ovarian neoplasms; recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Diagn Progn Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google